RAPIDLY-DISSOLVING PHARMACEUTICAL COMPOSITION FOR INHIBITING OVULATION

A rapidly-dissolving oral dosage pharmaceutical composition for inhibiting ovulation in a mammal, said composition comprising drospirenone or a pharmaceutically acceptable salt or ester thereof, optionally ethinyl estradiol or a pharmaceutically acceptable salt, ester or ether thereof, a surfactant...

Full description

Saved in:
Bibliographic Details
Main Authors PANIAGUA MARCOS, PAOLA HENAR, LORENZO PAJUELO, BENITO, DAVILA ZAVALA, PABLO
Format Patent
LanguageEnglish
French
Published 29.03.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A rapidly-dissolving oral dosage pharmaceutical composition for inhibiting ovulation in a mammal, said composition comprising drospirenone or a pharmaceutically acceptable salt or ester thereof, optionally ethinyl estradiol or a pharmaceutically acceptable salt, ester or ether thereof, a surfactant and at least one pharmaceutically acceptable excipient, wherein the drospirenone has a surface area of less than 10,000 cm2/g. L'invention concerne une composition pharmaceutique dosifiée orale à dissolution rapide, destinée à inhiber l'ovulation chez un mammifère. Cette composition contient de la drospirénone ou un sel ou un ester pharmaceutiquement acceptable de celle-ci, facultativement de l'éthinyl estradiol ou un sel, un ester ou un éther pharmaceutiquement acceptable de celui-ci, un tensioactif et au moins un excipient pharmaceutiquement acceptable, la drospirénone présentant une surface active inférieure à 10 000 cm2/g.
Bibliography:Application Number: WO2006EP62848